Immunocore Holdings plc financial data

Symbol
IMCR on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
90 Park Drive, Milton Park, Abingdon, Oxfordshire, United Kingdom
Fiscal year end
December 31
Former names
Immunocore Ltd (to 2/1/2021)
Latest financial report
10-K - Q4 2024 - Feb 26, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 466 %
Quick Ratio 2.15 %
Debt-to-equity 182 %
Return On Equity -14 % +10.1%
Return On Assets -4.97 %
Operating Margin -23 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 50.1M shares +0.5%
Common Stock, Shares, Outstanding 50.1M shares +0.68%
Entity Public Float 1.6B USD -40.7%
Common Stock, Value, Issued 135K USD +0.75%
Weighted Average Number of Shares Outstanding, Basic 50M shares +2.25%
Weighted Average Number of Shares Outstanding, Diluted 50M shares +2.25%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 296M USD +23.7%
Cost of Revenue 2.73M USD +163%
Research and Development Expense 222M USD +35.8%
Operating Income (Loss) -70.5M USD -18.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -52.9M USD +13.1%
Income Tax Expense (Benefit) -1.85M USD +67%
Net Income (Loss) Attributable to Parent -51.1M USD +7.6%
Earnings Per Share, Basic -1.02 USD/shares +9.74%
Earnings Per Share, Diluted -1.02 USD/shares +9.74%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 456M USD +2.96%
Marketable Securities, Current 365M USD
Accounts Receivable, after Allowance for Credit Loss, Current 63M USD +21%
Inventory, Net 5.45M USD +21%
Other Assets, Current 7.9M USD -18.7%
Assets, Current 930M USD +75.8%
Deferred Income Tax Assets, Net 14.8M USD +34.8%
Property, Plant and Equipment, Net 10.1M USD +9.52%
Operating Lease, Right-of-Use Asset 37.6M USD +12.3%
Other Assets, Noncurrent 17.1M USD +18.3%
Assets 1.01B USD +69.1%
Accounts Payable, Current 25.1M USD +41%
Employee-related Liabilities, Current 13.1M USD +13%
Liabilities, Current 212M USD +52.6%
Operating Lease, Liability, Noncurrent 40.2M USD +12.8%
Liabilities 649M USD +184%
Accumulated Other Comprehensive Income (Loss), Net of Tax -33.8M USD +6.89%
Retained Earnings (Accumulated Deficit) -796M USD -6.86%
Stockholders' Equity Attributable to Parent 361M USD -2.2%
Liabilities and Equity 1.01B USD +69.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.59M USD -144%
Net Cash Provided by (Used in) Financing Activities 396M USD +6351%
Net Cash Provided by (Used in) Investing Activities -430K USD +85.7%
Common Stock, Shares, Issued 50.1M shares +0.68%
Common Stock, Par or Stated Value Per Share 0 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 456M USD +2.96%
Deferred Tax Assets, Valuation Allowance 92.2M USD +10.9%
Deferred Tax Assets, Gross 110M USD +15.2%
Operating Lease, Liability 41.7M USD +15.8%
Depreciation 1.01M USD +6.2%
Payments to Acquire Property, Plant, and Equipment 430K USD -85.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -48.6M USD -31.8%
Lessee, Operating Lease, Liability, to be Paid 65.6M USD +6.97%
Property, Plant and Equipment, Gross 65.4M USD +6.33%
Operating Lease, Liability, Current 1.55M USD +11.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.56M USD +17.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.31M USD +11.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 23.9M USD -5.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.46M USD +16.2%
Deferred Tax Assets, Operating Loss Carryforwards 69.4M USD -7.43%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.7M USD +28.2%
Additional Paid in Capital 1.19B USD +3.52%
Interest Expense 3.24M USD +159%